⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5460849 | 0.84 | — | — | |
| SCHEMBL6503661 | 0.82 | LMNA (0.52) | — | |
| SCHEMBL28745053 | 0.80 | MAPT (0.56) | — | |
| SCHEMBL8760590 | 0.76 | — | — | |
| SCHEMBL17493224 | 0.76 | — | — | |
| SCHEMBL4198312 | 0.73 | — | — | |
| SCHEMBL16308845 | 0.72 | LMNA (0.40) | — | |
| SCHEMBL1650435 | 0.72 | — | — | |
| SCHEMBL5439184 | 0.71 | — | — | |
| SCHEMBL536652 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112759579-B | Preparation method of antitumor drug tegafur | 鲁南制药集团股份有限公司 | 2023-12-26 | — | — | CN | claimed |
| CN-112759579-A | Preparation method of antineoplastic drug tegafur | 鲁南制药集团股份有限公司 | 2021-05-07 | — | — | CN | claimed |
| EP-0392317-B1 | Benzimidazoles, drugs containing these compounds and process for their preparation | THOMAE GMBH DR K (DE) | 1996-01-03 | — | — | EP | claimed |
| CN-112759579-B | Preparation method of antitumor drug tegafur | 鲁南制药集团股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-112759579-B | Preparation method of antitumor drug tegafur | 鲁南制药集团股份有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-116265456-A | Synthesis method of posaconazole mother ring with high chiral purity | 苏州汉德创宏生化科技有限公司 | 2023-06-20 | — | — | CN | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| CN-112759579-A | Preparation method of antineoplastic drug tegafur | 鲁南制药集团股份有限公司 | 2021-05-07 | — | — | CN | disclosed |
| CN-112759579-A | Preparation method of antineoplastic drug tegafur | 鲁南制药集团股份有限公司 | 2021-05-07 | — | — | CN | disclosed |
| US-20160367691-A1 | TARGETED ENZYME COMPOUNDS AND USES THEREOF | ANGIOCHEM INC (CA) | 2016-12-22 | — | — | US | disclosed |
| EP-2076129-B1 | NOVEL CURCUMIN DIMER | UNIV CITY NEW YORK RES FOUND (US) | 2016-05-04 | — | — | EP | disclosed |
| US-8487139-B2 | Curcumin and tetrahydrocurcumin derivatives | THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK | 2013-07-16 | — | — | US | disclosed |
| US-20100240905-A1 | Novel Curcumin and Tetrahydrocurcumin Derivatives | RESEARCH FOUNDATION OF CITY UNIVERSITY OF NEW YORK (US) | 2010-09-23 | — | — | US | disclosed |
| US-20100226871-A1 | HIGH INTENSITY FRAGRANCES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-09-09 | — | — | US | disclosed |
| EP-2076129-A2 | NOVEL CURCUMIN AND TETRAHYDROCURCUMIN DERIVATIVES | The Research Foundation Of the City university of New York (US) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008045534-A2 | NOVEL CURCUMIN AND TETRAHYDROCURCUMIN DERIVATIVES | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2008-04-17 | — | — | WO | disclosed |
| US-5864043-A | CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST | KARL THOMAE GMBH (DE) | 1999-01-26 | — | — | US | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| EP-0136586-B1 | NOVEL CORTICOID DERIVATIVES AND PROCESS FOR PRODUCTION THEREOF | MITSUBISHI KASEI CORPORATION (JP) | 1989-03-01 | — | — | EP | disclosed |
| US-4046636-A | FOR DETERMINATION OF BENZDIAZACYCLOHEPTANE DRUGS | SYVA COMPANY (US) | 1977-09-06 | — | — | US | disclosed |